Linde AG   Report issue

For profit Phase 3
Founded: Wiesbaden United States (1879)
Status: Acquired by BOC International (1978)

Organization Overview

First Clinical Trial
2004
NCT00192959
First Marketed Drug
2013
oxygen
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Airco | Linde AG | LINDE GAS EQUIP | LINDE GAS NORTH AMERICA LLC | LINDE GAS PUERTO RICO INC | LINDE MERCHANT PRODUCTIONS INC | LINDE NORTH AMERICA INC

Active Ingredients

Marketed Drugs (5)

carbon dioxide (dry ice) (2013)

helium (2014)

nitric oxide (inomax) (2018)

nitrogen (2013)

oxygen (2013)

Drugs in Phase 3 Trials (2)

propofol (diprivan) (1 trial)

xenon xe-133 (1 trial)

Drugs in Other Trials (2)

nitrous oxide (1 trial)

oxygen (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Respiratory Aspiration (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 4